Mevastatin

Mevastatin

Identifiers
IUPAC name Compactin
CAS Number	73573-88-3
PubChem CID	64715
DrugBank	EXPT00012
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C23H36O6
Molar mass	408.534 g/mol

WikiDoc Resources for Mevastatin
Articles
Most recent articles on Mevastatin Most cited articles on Mevastatin Review articles on Mevastatin Articles on Mevastatin in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Mevastatin Images of Mevastatin Photos of Mevastatin Podcasts & MP3s on Mevastatin Videos on Mevastatin
Evidence Based Medicine
Cochrane Collaboration on Mevastatin Bandolier on Mevastatin TRIP on Mevastatin
Clinical Trials
Ongoing Trials on Mevastatin at Clinical Trials.gov Trial results on Mevastatin Clinical Trials on Mevastatin at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Mevastatin NICE Guidance on Mevastatin NHS PRODIGY Guidance FDA on Mevastatin CDC on Mevastatin
Books
Books on Mevastatin
News
Mevastatin in the news Be alerted to news on Mevastatin News trends on Mevastatin
Commentary
Blogs on Mevastatin
Definitions
Definitions of Mevastatin
Patient Resources / Community
Patient resources on Mevastatin Discussion groups on Mevastatin Patient Handouts on Mevastatin Directions to Hospitals Treating Mevastatin Risk calculators and risk factors for Mevastatin
Healthcare Provider Resources
Symptoms of Mevastatin Causes & Risk Factors for Mevastatin Diagnostic studies for Mevastatin Treatment of Mevastatin
Continuing Medical Education (CME)
CME Programs on Mevastatin
International
Mevastatin en Espanol Mevastatin en Francais
Business
Mevastatin in the Marketplace Patents on Mevastatin
Experimental / Informatics
List of terms related to Mevastatin

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Mevastatin, compactin, ML-236B is a hypolipidemic agent that belongs to the statins class.

It was the first compound isolated in the 1970s during research into HMG-CoA reductase inhibitors produced by a mould Penicillium citrinum.

Nowadays, Mevastatin is not used in therapy of hyperlipidemias because of multiple side effects but it is the only source for production of other statin - pravastatin.

Mechanisms of Action

Mevastatin inhibits isoprenoid biosynthesis by inhibition of HMG-CoA reductase (Ki for acid form is 1 nM)1 and therefore blocks protein isoprenylation and reduces plasma cholesterol levels in humans. It causes cells to arrest early in the G1 phase.

Mevastatin is a close structural analog of lovastatin and both agents have the same biochemical and pharmacological activities. Mevastatin is inactive in cell-free assays. In cells however, it is hydrolyzed to the active free acid form by intracellular esterases.

References

Template:WikiDoc Sources